The Four-State Telehealth Map

Question 73: The Four-State Telehealth Map

Your role

You represent Clearpath Behavioral Care, which wants to launch video visits for antidepressant management and stimulant treatment in four fictional states. Apply only the supplied licensure and prescribing matrix and produce a lawful rollout map by state.

Governing law

The following general rules apply in every state unless the state matrix is more specific:

1. A telehealth encounter occurs where the patient is physically located at the time of service. The clinician must satisfy that state's licensure rule for each encounter.

2. The provider must verify and document the patient's physical location at the start of each visit.

3. Telehealth informed consent must be obtained before the first telehealth service and documented in the record.

4. A prescription requires an adequate clinical evaluation in the modality permitted by the patient's state and compliance with any controlled-substance condition in the matrix.

5. An antidepressant is a noncontrolled medication for this assignment. The stimulant is a controlled medication.

6. A compact privilege, telehealth registration, or full license authorizes only the scope stated in the matrix. One authorization cannot be treated as another.

7. An in-person examination by an unaffiliated outside clinician satisfies a state condition only if the matrix expressly says so.

8. Entity permits and individual clinician authority are separate requirements when the matrix requires both.

State matrix

State Alder

• The treating clinician must hold a full Alder license; no compact privilege or registration is recognized.
• Video evaluation is permitted for noncontrolled medication.
• A controlled stimulant may be prescribed only if the same practice conducted an in-person examination within the preceding 12 months.

State Birch

• A recognized compact privilege is sufficient.
• Video evaluation is permitted for both noncontrolled and controlled medication.
• Before each stimulant prescription, the clinician must check the state prescription-monitoring database and document the check.

State Cedar

• The clinician must hold a full Cedar license, and the telehealth company must hold a Cedar entity permit.
• Video evaluation is permitted for noncontrolled medication.
• The first controlled prescription requires an in-person examination by the prescribing practice. Later video renewals are permitted for 12 months after that examination.

State Dune

• An approved Dune telehealth registration is sufficient for noncontrolled treatment.
• A registrant may not prescribe a controlled substance by telehealth under any circumstance.
• A full Dune license is required for controlled prescribing, and Clearpath has no fully licensed Dune clinician.

Facts

Clearpath has two clinicians:

• Dr. Rowan Lee holds a full Alder license, a recognized Birch compact privilege, and an approved Dune telehealth registration. Dr. Lee is not licensed in Cedar.
• Nurse Practitioner Amaya Vale holds a full Cedar license and no authority in Alder, Birch, or Dune.

Clearpath holds a Cedar entity permit. It operates physical clinics in Alder and Cedar but none in Birch or Dune.

Clearpath proposes:

1. Video antidepressant evaluation and prescribing for new patients in all four states.
2. Video stimulant evaluation and first prescribing for new patients in all four states.
3. Video stimulant renewals for patients who had an in-person examination with an outside primary-care clinician during the prior year.

Clearpath's platform can verify patient location, capture telehealth consent, and connect to Birch's monitoring database. Marketing wants to advertise “fully virtual ADHD treatment in all four states.”

Assignment

Analyze and map:

• Which clinician may provide video antidepressant care in each state.
• Whether Clearpath satisfies every entity-permit requirement.
• New-patient stimulant prescribing in each state.
• Whether an outside primary-care examination satisfies Alder or Cedar.
• Lawful stimulant-renewal pathways.
• Required location, consent, and monitoring steps.
• Which proposed services must be blocked by the platform.
• The accurate state-by-state rollout and the marketing claim Clearpath may make.

Q73 key (Four-State Telehealth Map)

1. Antidepressants: Dr. Lee may treat Alder patients under the full license, Birch patients under the compact privilege, and Dune patients under the registration. NP Vale may treat Cedar patients, and Clearpath's Cedar entity permit completes that state's requirements. Missed: one clinician's authority is generalized across states.
2. New stimulants: Alder permits Dr. Lee only after Clearpath's same practice performs an in-person examination within 12 months; Birch permits Dr. Lee after video evaluation plus documented monitoring-database check; Cedar permits NP Vale only after Clearpath conducts the first visit in person; Dune permits none because registration bars controlled telehealth and no full Dune license exists. Missed: a four-state virtual launch creates unlicensed or prohibited prescribing.
3. An outside primary-care examination satisfies neither Alder's same-practice condition nor Cedar's prescribing-practice condition. Clearpath's Alder and Cedar clinics can create lawful hybrid pathways; Birch needs no in-person visit under the supplied matrix. Missed: unrelated examinations are treated as statutory substitutes.
4. Renewals: Alder video renewal is lawful for 12 months after Clearpath's in-person exam; Birch renewal is lawful with each required database check; Cedar renewal is lawful for 12 months after Clearpath's in-person first exam; Dune stimulant renewal remains blocked. Missed: an initial barrier is fixed but renewals are left ungoverned.
5. Every visit must verify patient location and document telehealth consent. The platform must route only to an authorized clinician, require Birch database documentation, and hard-block stimulant orders when state conditions are unmet. Missed: compliance is left to marketing or clinician memory.
6. Advertise fully virtual antidepressant care in all four states with the stated clinician coverage. Do not advertise fully virtual ADHD treatment in all four: Birch is virtual, Alder and Cedar are hybrid, and Dune is unavailable. Missed: a false rollout claim drives prohibited encounters.